Integrated testing for TB and COVID-19

Emily L. MacLean; Luz Villa-Castillo; Morten Ruhwald; César Ugarte-Gil; Madhukar Pai

doi:10.1016/j.medj.2022.02.002

Integrated testing for TB and COVID-19

Emily L. MacLean, Luz Villa-Castillo, Morten Ruhwald, César Ugarte-Gil, Madhukar Pai

Research output: Contribution to journal › Comment/debate › peer-review

11 Scopus citations

Abstract

Integrated testing for TB and COVID-19 may help find those TB patients who are not accessing care in the context of the COVID-19 pandemic. Some molecular platforms with assays for both diseases are already commercially available; however, integrated testing approaches need to be systematically evaluated to ensure their appropriate implementation.

Original language	English (US)
Pages (from-to)	162-166
Number of pages	5
Journal	Med
Volume	3
Issue number	3
DOIs	https://doi.org/10.1016/j.medj.2022.02.002
State	Published - Mar 11 2022
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.medj.2022.02.002

Cite this

@article{fe42fdd19b264726a9370b6e143decf3,

title = "Integrated testing for TB and COVID-19",

abstract = "Integrated testing for TB and COVID-19 may help find those TB patients who are not accessing care in the context of the COVID-19 pandemic. Some molecular platforms with assays for both diseases are already commercially available; however, integrated testing approaches need to be systematically evaluated to ensure their appropriate implementation.",

author = "MacLean, {Emily L.} and Luz Villa-Castillo and Morten Ruhwald and C{\'e}sar Ugarte-Gil and Madhukar Pai",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",

year = "2022",

month = mar,

day = "11",

doi = "10.1016/j.medj.2022.02.002",

language = "English (US)",

volume = "3",

pages = "162--166",

journal = "Med",

issn = "2666-6359",

publisher = "Cell Press",

number = "3",

}

TY - JOUR

T1 - Integrated testing for TB and COVID-19

AU - MacLean, Emily L.

AU - Villa-Castillo, Luz

AU - Ruhwald, Morten

AU - Ugarte-Gil, César

AU - Pai, Madhukar

PY - 2022/3/11

Y1 - 2022/3/11

N2 - Integrated testing for TB and COVID-19 may help find those TB patients who are not accessing care in the context of the COVID-19 pandemic. Some molecular platforms with assays for both diseases are already commercially available; however, integrated testing approaches need to be systematically evaluated to ensure their appropriate implementation.

AB - Integrated testing for TB and COVID-19 may help find those TB patients who are not accessing care in the context of the COVID-19 pandemic. Some molecular platforms with assays for both diseases are already commercially available; however, integrated testing approaches need to be systematically evaluated to ensure their appropriate implementation.

UR - http://www.scopus.com/inward/record.url?scp=85125652773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85125652773&partnerID=8YFLogxK

U2 - 10.1016/j.medj.2022.02.002

DO - 10.1016/j.medj.2022.02.002

M3 - Comment/debate

C2 - 35169763

AN - SCOPUS:85125652773

SN - 2666-6359

VL - 3

SP - 162

EP - 166

JO - Med

JF - Med

IS - 3

ER -

Integrated testing for TB and COVID-19

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this